A2M and cancer: Fucoidan also affected the senescence of Chang-L cells by decreasing mRNA expression of p16INK4a, p14Arf, p21 and the senescence biomarker α2M. These findings suggest that fucoidan may offer substantial therapeutic potential for cancer treatment without inducing senescence in normal cells, and that it may be possible to use fucoidan therapeutically.